SNORA18 and hepatocellular carcinoma: Based on our data, we also found that SNORA18 knockdown could reverse the alteration of biological function in HCC cells treated with DDX24-specific shRNA and SFN by regulating the AKT/ERK, EMT and caspase/PARP pathways.